-
Mashup Score: 29Establishing a Workable Treatment Algorithm for JELMYTO® for Low-Grade Upper Tract Urothelial Carcinoma- Amy Luckenbaugh - 6 month(s) ago
In this discussion, Sam Chang hosts Amy Luckenbaugh, who shares her experience establishing a new treatment program for patients with low-grade upper tract urothelial carcinoma at Vanderbilt, using a novel agent called JELMYTO® (mitomycin). This reverse thermal hydrogel is administered either retrograde or antegrade and has shown encouraging outcomes, with a complete response rate of 58%….
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 11
Sam Chang interviews Jonathan Coleman and Wesley Yip. They delve into a Journal of Urology article detailing promising advancements in treating upper tract disease using photodynamic therapy, a non-invasive treatment method developed by Drs. Coleman and Yip. Their study seeks to decrease over-treatment of the disease, which often results in unnecessary kidney removal. Preliminary results show…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Final results of a phase I trial of WST-11 (TOOKAD Soluble) vascular-targeted photodynamic therapy for #UTUC. @WesleyYipMD and Jonathan Coleman, MD @UrologyMSK join @UroCancerMD @VUMCurology to discuss on UroToday > https://t.co/o4T8qK0LKu @JUrology https://t.co/AEbE1Nld1D
-
-
Mashup Score: 3
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Unpacking the @AmerUrological guidelines: Neoadjuvant chemotherapy and surveillance in non-metastatic #UTUC. @RKSayyid @UofT & @zklaassen_md @GACancerCenter discuss in this conversation on UroToday > https://t.co/6HOfzM9ThM https://t.co/d7LMV9V6HT
-
-
Mashup Score: 6
Katie Murray joins Alicia Morgans to discuss reverse thermal mitomycin (JEMLYTO®) for primary chemoablation of upper tract urothelial carcinoma (UTUC) via a percutaneous nephrostomy tube. Based on results from the pivotal OLYMPUS trial, JELMYTO® is currently approved for low-grade UTUC. Dr. Murray speaks to two different methods of administration of the mitomycin gel that was allowed in this…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Antegrade administration of reverse thermal mitomycin gel for primary chemoablation of #UTUC via percutaneous nephrostomy tube. @KSMurrayUro @MizzouUrology joins @CaPsurvivorship @DanaFarber in this discussion on UroToday > https://t.co/xB8YWsk8n1 @jelmyto https://t.co/UGuHAyrtF7
-
-
Mashup Score: 29Establishing a Workable Treatment Algorithm for JELMYTO® for Low-Grade Upper Tract Urothelial Carcinoma- Amy Luckenbaugh - 7 month(s) ago
In this discussion, Sam Chang hosts Amy Luckenbaugh, who shares her experience establishing a new treatment program for patients with low-grade upper tract urothelial carcinoma at Vanderbilt, using a novel agent called JELMYTO® (mitomycin). This reverse thermal hydrogel is administered either retrograde or antegrade and has shown encouraging outcomes, with a complete response rate of 58%….
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Establishing a workable treatment algorithm for @jelmyto® for low-grade #UTUC. @AmyLuckenbaugh @VUMChealth joins @UroCancerMD @VUMCurology to share her experience establishing a new treatment program > https://t.co/yVz2KX8b45 https://t.co/9suSfrGatg
-
-
Mashup Score: 0Management of Low-Grade Upper Tract Urothelial Carcinoma: Case-Based Presentation - Rashid Sayyid - 7 month(s) ago
Zachary Klaassen is joined by Rashid Sayyid to present a case-based discussion on the management of low-grade upper tract urothelial carcinoma. They focus on a 68-year-old female patient, detailing her medical history, symptoms, and diagnostic workup, including CT urogram, according to the American Urological Association (AUA) guidelines. They explore various considerations such as standardized…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Management of low-grade upper tract #UrothelialCarcinoma #UTUC: A case-based presentation. @RKSayyid @UofT and @zklaassen_md @GACancerCenter explore various considerations in this discussion on UroToday > https://t.co/U8hLz5uVYp https://t.co/8ddaeEJaMV
-
-
Mashup Score: 0Guidelines and Real-World Scenarios in Upper Tract Urothelial Carcinoma Treatment - Kyle Rose - 7 month(s) ago
In a case presentation, Zach Klaassen and Kyle Rose discuss the complexities of treating low-grade upper tract urothelial carcinoma. Dr. Rose presents a case of a 69-year-old male patient with the condition, emphasizing the importance of thorough workup and staging. The discussion covers the challenges of accurate biopsy sampling and the potential for under-staging or over-staging patients. Dr….
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Guidelines and real-world scenarios in upper tract #UrothelialCarcinoma treatment. @KyleRoseMD @OchsnerHealth and @zklaassen_md @GACancerCenter discuss the complexities of treating low-grade #UTUC in this case-presentation on UroToday > https://t.co/sPWDnrFvXs https://t.co/7L43Te2e7p
-
-
Mashup Score: 0Choosing JELMYTO®: A Patient's Journey Through Less Invasive Upper Tract Urothelial Carcinoma Treatment - Tom Murphy - 7 month(s) ago
In the wake of being diagnosed with upper tract urothelial cancer (UTUC), patient Tom Murphy navigates through his treatment options, ultimately settling on JELMYTO® (mitomycin) treatment. This less invasive procedure consists of six weekly treatments which were, according to Murphy, relatively simple and unobtrusive to his everyday life. Expressing gratitude for the guidance and support of his…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Choosing @jelmyto: A patient's journey through less invasive upper tract #UrothelialCarcinoma treatment. Tom Murphy guides us through his treatment options and decisions after his #UTUC diagnosis. #WatchNow on UroToday > https://t.co/F2w2TZm69t @UroGenPharma https://t.co/2TWNIALgib
-
-
Mashup Score: 0
Sam Chang interviews Jonathan Coleman and Wesley Yip. They delve into a Journal of Urology article detailing promising advancements in treating upper tract disease using photodynamic therapy, a non-invasive treatment method developed by Drs. Coleman and Yip. Their study seeks to decrease over-treatment of the disease, which often results in unnecessary kidney removal. Preliminary results show…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Final results of a phase I trial of WST-11 (TOOKAD Soluble) vascular-targeted photodynamic therapy for #UTUC. @WesleyYipMD and Jonathan Coleman, MD @UrologyMSK join @UroCancerMD @VUMCurology to discuss on UroToday > https://t.co/o4T8qK0LKu @JUrology https://t.co/hzkuAVpHDx
-
-
Mashup Score: 0
ROBUUST Collaborative Group, Upper tract urothelial carcinoma (UTUC), bladder cancer, Oncological Outcomes in Upper Tract Urothelial Carcinoma, Robotic surgery for Upper tract Urothelial cancer Study (ROBUUST).
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What is the impact of variant histology on oncological outcomes in #UTUC? @alirezaghoreifi, @douglawi, and @Hoomandjaladat discuss results From the #ROBUUST Collaborative Group. #BeyondTheAbstract on UroToday > https://t.co/lneq3XeBKj @KeckMedUSC https://t.co/xFzdk2qL9Y
-
Establishing a workable treatment algorithm for @jelmyto® for low-grade #UTUC. @AmyLuckenbaugh @VUMChealth joins @UroCancerMD @VUMCurology to share her experience establishing a new treatment program > https://t.co/yVz2KX8b45 https://t.co/9suSfrGatg